Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock Holdings Increased by Swiss National Bank

Swiss National Bank lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.3% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,052,800 shares of the medical equipment provider’s stock after purchasing an additional 3,400 shares during the quarter. Swiss National Bank owned 0.30% of Intuitive Surgical worth $517,209,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also made changes to their positions in ISRG. International Assets Investment Management LLC lifted its position in shares of Intuitive Surgical by 49,383.6% in the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock worth $535,788,000 after purchasing an additional 1,088,415 shares in the last quarter. Capital Research Global Investors purchased a new stake in shares of Intuitive Surgical in the first quarter worth approximately $374,390,000. Strategic Financial Concepts LLC lifted its position in shares of Intuitive Surgical by 40,221.4% in the second quarter. Strategic Financial Concepts LLC now owns 266,121 shares of the medical equipment provider’s stock worth $1,184,000 after purchasing an additional 265,461 shares in the last quarter. GQG Partners LLC purchased a new stake in shares of Intuitive Surgical in the first quarter worth approximately $99,523,000. Finally, Canada Pension Plan Investment Board lifted its position in shares of Intuitive Surgical by 36.4% in the first quarter. Canada Pension Plan Investment Board now owns 807,780 shares of the medical equipment provider’s stock worth $322,377,000 after purchasing an additional 215,444 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Trading Down 1.9 %

Intuitive Surgical stock opened at $527.61 on Friday. The company has a market capitalization of $187.92 billion, a PE ratio of 84.82, a P/E/G ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $295.02 and a 12 month high of $544.38. The stock has a 50-day moving average price of $499.29 and a two-hundred day moving average price of $457.89.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The business had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. As a group, analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Insider Activity at Intuitive Surgical

In related news, Director Amy L. Ladd sold 450 shares of Intuitive Surgical stock in a transaction on Friday, September 13th. The stock was sold at an average price of $490.28, for a total transaction of $220,626.00. Following the completion of the sale, the director now owns 821 shares of the company’s stock, valued at approximately $402,519.88. This trade represents a 35.41 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Jamie Samath sold 22,903 shares of the firm’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $525.00, for a total value of $12,024,075.00. Following the sale, the insider now owns 8,757 shares in the company, valued at $4,597,425. The trade was a 72.34 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 91,178 shares of company stock valued at $45,897,071. 0.90% of the stock is owned by insiders.

Analysts Set New Price Targets

Several brokerages recently weighed in on ISRG. JPMorgan Chase & Co. raised their price objective on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Mizuho raised their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Stifel Nicolaus raised their price objective on shares of Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a research report on Friday, October 18th. The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Wells Fargo & Company raised their price objective on shares of Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a research report on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $513.74.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.